JP2018523703A5 - - Google Patents

Download PDF

Info

Publication number
JP2018523703A5
JP2018523703A5 JP2018521713A JP2018521713A JP2018523703A5 JP 2018523703 A5 JP2018523703 A5 JP 2018523703A5 JP 2018521713 A JP2018521713 A JP 2018521713A JP 2018521713 A JP2018521713 A JP 2018521713A JP 2018523703 A5 JP2018523703 A5 JP 2018523703A5
Authority
JP
Japan
Prior art keywords
peptide
inflammatory
composition
amino acid
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018521713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018523703A (ja
Filing date
Publication date
Priority claimed from EP15177017.9A external-priority patent/EP3118216A1/en
Priority claimed from EP15177013.8A external-priority patent/EP3118215A1/en
Application filed filed Critical
Priority claimed from PCT/EP2016/067090 external-priority patent/WO2017009484A1/en
Publication of JP2018523703A publication Critical patent/JP2018523703A/ja
Publication of JP2018523703A5 publication Critical patent/JP2018523703A5/ja
Priority to JP2021173218A priority Critical patent/JP7288026B2/ja
Pending legal-status Critical Current

Links

JP2018521713A 2015-07-16 2016-07-18 抗炎症性ペプチドおよびその使用 Pending JP2018523703A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021173218A JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15177017.9A EP3118216A1 (en) 2015-07-16 2015-07-16 Cellular growth and proliferation promoting peptides, and uses thereof
EP15177017.9 2015-07-16
EP15177013.8A EP3118215A1 (en) 2015-07-16 2015-07-16 Anti-inflammatory peptides, and uses thereof
EP15177013.8 2015-07-16
PCT/EP2016/067090 WO2017009484A1 (en) 2015-07-16 2016-07-18 Anti-inflammatory peptides, and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021173218A Division JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用

Publications (2)

Publication Number Publication Date
JP2018523703A JP2018523703A (ja) 2018-08-23
JP2018523703A5 true JP2018523703A5 (enExample) 2019-08-22

Family

ID=56686757

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018521713A Pending JP2018523703A (ja) 2015-07-16 2016-07-18 抗炎症性ペプチドおよびその使用
JP2021173218A Active JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用
JP2023086030A Active JP7739355B2 (ja) 2015-07-16 2023-05-25 抗炎症性ペプチドおよびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021173218A Active JP7288026B2 (ja) 2015-07-16 2021-10-22 抗炎症性ペプチドおよびその使用
JP2023086030A Active JP7739355B2 (ja) 2015-07-16 2023-05-25 抗炎症性ペプチドおよびその使用

Country Status (12)

Country Link
US (4) US10463591B2 (enExample)
EP (3) EP3747425A1 (enExample)
JP (3) JP2018523703A (enExample)
KR (3) KR102307260B1 (enExample)
CN (2) CN108348568B (enExample)
AU (2) AU2016293129B2 (enExample)
BR (1) BR112018000660A2 (enExample)
CA (1) CA2992378A1 (enExample)
DK (1) DK3322430T3 (enExample)
ES (1) ES2806989T3 (enExample)
MX (2) MX377692B (enExample)
WO (1) WO2017009484A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3057136T3 (en) * 2016-12-05 2026-02-26 Nuritas Ltd Compositions comprising peptide wkdeagkplvk
JP7340314B2 (ja) * 2020-01-15 2023-09-07 Tdk株式会社 米に含まれるタンパク質の含有量を測定する方法
KR102354916B1 (ko) * 2020-02-11 2022-01-26 주식회사 쓰리빅스 신규 펩타이드 3ps_i014 및 이의 용도
FR3114744B1 (fr) * 2020-10-02 2024-01-05 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer le confort de la peau et/ou des muqueuses et/ou l’apparence des phanères
WO2022131820A1 (ko) * 2020-12-16 2022-06-23 아주대학교산학협력단 아토피 피부염 예방 또는 치료용 항염증 펩타이드
CN114478702B (zh) * 2022-04-06 2023-12-12 中南林业科技大学 一种米糠来源短肽及其在治疗皮肤损伤中的应用
CN116253782B (zh) * 2022-09-08 2024-06-04 浙江大学 一种广谱抗菌肽ktr及其应用
CN116375828B (zh) * 2022-09-08 2024-06-04 浙江大学 一种具有抗菌活性的抗菌肽kta及其应用
FR3141066B1 (fr) 2022-10-24 2026-04-10 Basf Beauty Care Solutions France Sas Nouvelle utilisation d’un peptide pour améliorer la matrice extracellulaire du derme de la peau et/ou des muqueuses
CN116491631B (zh) * 2023-05-26 2024-06-25 青岛农业大学 一种预制菜红烧肉及其制备方法
WO2024259556A1 (en) * 2023-06-19 2024-12-26 Viage Therapeutics, Inc. Uses of therapeutic peptides
CN117736271B (zh) * 2023-06-29 2024-08-09 长沙理工大学 一种米渣蛋白源免疫活性肽及其应用
AU2024402215A1 (en) * 2023-12-20 2026-06-25 Nuritas Limited Sleep promoting peptides and the use thereof
CN117986337B (zh) * 2024-02-02 2024-08-16 杭州御寿生物科技有限公司 一种提高免疫力的益生菌组合物以及在治疗疾病中的应用
EP4666996A1 (en) * 2024-06-21 2025-12-24 Quiris Healthcare GmbH & Co. KG Composition containing peptides of vegetable origin
CN120590476B (zh) * 2025-08-06 2026-06-19 浙江诺衍生物科技有限公司 一种有助于降血糖的七肽及其应用
CN120574921B (zh) * 2025-08-06 2026-02-06 浙江诺衍生物科技有限公司 一种有助于降血糖的大米肽及其应用
TWI923521B (zh) * 2025-10-14 2026-04-21 丹荷萊雪有限公司 十一胜肽及其在美白皮膚以及抗氧化上的用途

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5520935A (en) 1991-03-07 1996-05-28 Novo Nordisk A/S Method for production of pea protein hydrolyzate
US5516642A (en) 1992-11-16 1996-05-14 Bristol-Myers Squibb Company Polypeptides derived from major histocompatibility complex Class I antigen
JP2673659B2 (ja) 1994-02-11 1997-11-05 株式会社ホーネンコーポレーション ペプチド
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US20040031072A1 (en) 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
IT1313572B1 (it) 1999-07-27 2002-09-09 Enichem Spa Procedimento per la preparazione di epossidi.
US20110131679A2 (en) 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
JP2001335596A (ja) 2000-05-24 2001-12-04 Kenji Sakamoto 新規ペプチド及びその医薬用途
AU2002338614A1 (en) 2001-04-17 2002-10-28 Femtolink Biotechnologies Llc Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
US7537914B1 (en) 2002-11-04 2009-05-26 Florida State University Research Foundation, Inc. Nucleic acid and allergenic polypeptides encoded thereby in cashew nuts (Anacardium occidentale)
SE0300795D0 (sv) 2003-03-24 2003-03-24 Isconova Ab Composition comprising iscom particles and live micro-organisms
JP2006526022A (ja) 2003-05-23 2006-11-16 ペスカ バイオメディカル ラボラトリーズ， インク． 重症急性呼吸器症候群及び他のウィルス感染の治療のためのインターフェロンの使用
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
US20070053845A1 (en) 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
AU2006263332B2 (en) 2005-06-29 2012-02-23 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
US8105572B2 (en) 2007-05-18 2012-01-31 New York University Method of treating tuberculosis with interferons
KR100759495B1 (ko) 2006-02-17 2007-09-18 재단법인서울대학교산학협력재단 친수성 생리활성 펩타이드와 소수성 물질을 포함한자기조립 나노구조체
KR101652778B1 (ko) 2006-04-21 2016-08-31 가부시키가이샤 메이지 펩티드를 유효 성분으로서 함유하는 조성물
US9034402B2 (en) 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
ES2716864T3 (es) 2007-06-06 2019-06-17 Monsanto Technology Llc Genes y usos para la mejora de plantas
AU2008291682B2 (en) * 2007-08-24 2012-09-13 Mylexa Pty Limited Modulators of hypersensitivity reactions
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
US20120157395A1 (en) * 2009-07-13 2012-06-21 Masahisa Ibuki Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
WO2011122937A1 (en) 2010-03-29 2011-10-06 N.V. Nutricia Pea protein peptides with anti helicobacter pylori activity
ES2397890B1 (es) 2011-03-25 2014-02-07 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
EP2793605A1 (en) * 2011-12-21 2014-10-29 Laboratorios Ordesa, S.L Process for obtaining rice protein hydrolysates useful in the prevention and/or treatment of obesity
WO2014036562A2 (en) 2012-08-31 2014-03-06 University Of Virginia Patent Foundation Target peptides for immunotherapy and diagnostics
ES2676436T3 (es) * 2013-02-19 2018-07-19 Danone, S.A. Péptidos funcionales para trastornos de obesidad
CN105708748B (zh) 2014-12-04 2020-06-30 玫琳凯有限公司 化妆品组合物
US20170183386A1 (en) 2015-07-16 2017-06-29 Nuritas Limited Peptides, and uses thereof

Similar Documents

Publication Publication Date Title
JP2018503668A5 (enExample)
Huang et al. Metallacyclic assembly of interlocked superstructures
JP2012255007A5 (enExample)
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
JP2017528419A5 (enExample)
JP2010215657A5 (enExample)
JP2017523985A5 (enExample)
HRP20161677T1 (hr) Pegilirani fab protiv amiloida beta
JP2016512248A5 (enExample)
IL300540A (en) Preparation method for drug conjugates - antibody against - HER3
HRP20221021T1 (hr) T stanični receptori specifični za kompleks tumorskog antigena ny-eso-1 sa hla-a*02
HRP20151215T1 (hr) Anti-nr10 protutijela i njihova uporaba
JP2006502741A5 (enExample)
FI3065763T4 (fi) Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
HRP20231437T1 (hr) Il-15 i il-15ralpha sushi domena na temelju modulokina
JP2018500385A5 (enExample)
JP2016506727A5 (enExample)
EP3406347A3 (en) Xten conjugate compositions and methods of making same
WO2011084808A3 (en) Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
WO2008118017A3 (en) Prame derived peptides and immunogenic compositions comprising these
JP2014502955A5 (enExample)
WO2014151200A3 (en) Guanylate cyclase receptor agonists combined with other drugs
JP2016516065A5 (enExample)
HRP20160547T1 (hr) Pegilirani apelin i njegova upotreba